Diagnostic challenges in atypical breast cancer presentations initially managed as occult breast cancer: a case report of two patients
Background Occult breast cancer (OBC) is a rare breast carcinoma presenting with regional or distant metastasis in the absence of a clinically or radiologically detectable primary breast tumor. In practice, atypical presentations initially managed as OBC pose substantial diagnostic challenges. Subcutaneous nodules near the breast boundary may represent either isolated metastases or primary carcinomas arising in peripheral or ectopic breast tissue, and can mimic cutaneous adnexal malignancies. Furthermore, when an ambiguous breast lesion is biopsied without marker clip placement, subsequent neoadjuvant therapy can obscure the distinction between true OBC and a primary breast tumor achieving complete pathological regression. Case presentation We report two patients initially managed as OBC. Case 1, a 57-year-old woman, presented with a solitary subcutaneous nodule on the left anterior chest wall. Histopathological examination revealed invasive ductal carcinoma (no special type). Immunohistochemistry (IHC) showed estrogen receptor (ER) (+), GATA-binding protein 3 (GATA-3) (+), E-cadherin (+), progesterone receptor (PR) (-), and human epidermal growth factor receptor 2 (HER2) (-). Myoepithelial markers (calponin, p63, cytokeratin 5/6 [CK5/6]) and p40 were negative. Postoperative positron emission tomography-computed tomography (PET-CT) detected no hypermetabolic extramammary lesions. Although managed as an isolated subcutaneous metastasis of OBC (cT0cN0M1), a primary carcinoma in superior peripheral or ectopic breast tissue (pT1c cN0 M0) could not be excluded. Case 2, a 68-year-old woman, presented with fixed right axillary lymphadenopathy and an ipsilateral breast mass on magnetic resonance imaging (MRI) and computed tomography (CT). Pre-treatment vacuum-assisted biopsy (VAB) of the breast lesion showed adenosis with focal atypical ductal hyperplasia (ADH) without marker clip placement, whereas axillary core biopsy confirmed metastatic carcinoma (ER-, PR-, HER2 3+, GATA-3+, TRPS1+). After neoadjuvant anti-HER2 chemo-targeted therapy, the mastectomy specimen showed stromal fibrosis and foam cell hyperplasia without residual carcinoma, while microscopic metastasis (≤ 2.0 mm) persisted in three of six axillary nodes. This raised a diagnostic dilemma between true OBC and a primary breast carcinoma achieving breast pathological complete response (ypT0 ypN1mi). Conclusion Evaluating atypical breast malignancies requires comprehensive IHC profiling, biopsy clip localization, and close clinical, radiological, and pathological correlation.
Authors
- Yongcheng Zhang
- Huiying Chen
- Junhao Liao
Institutions
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fonc.2026.1958442
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00